Leighton Auditorium, 2nd Floor, Siebens Medical Education Building, 100 2nd Street Southwest, Rochester, Minnesota, 55902, United States
Both minimally disruptive medicine (MDM) and shared decision making (SDM) are heavily discussed during the course giving participants conceptual and practical knowledge of the topics. The course is divided into brief lectures and interactive workshops. Lectures provide a conceptual overview of MDM and SDM including Mayo Clinic's most recent research. Interactive workshops provide participants with tools that may be applied to individual practice and healthcare or research teams. Workshops provide space for conversations to discuss further developing MDM and SDM and implementing MDM and SDM tools and concepts into clinical practice.
BioPharm America is a unique partnering conference where the new wave of life science innovators partner to fuel the future of drug development. For the first time, this event will be held in Raleigh, North Carolina, September 13–14, 2023, a booming hub of research, innovation, manufacturing, and partnerships.
EBD Group is committed to providing a forum for the global biopharma community to come together from anywhere in the world that is why this year's event will also feature two additional days of digital partnering, September 18–19, 2023, in the week following the in-person event.
Over the last 16 years, BioPharm America bring together executives from major pharmaceutical companies, biotechnology companies of every size and stage, investors, and academic institutions to engage and drive drug development further. The event will cater to the needs of the entire value chain with thought-provoking program discussions, innovative company presentations and a variety of networking opportunities, making this an important forum for companies to meet and do business.
This year will also feature the return of the Startup Springboard, a lively competition offering a platform for 12 selected startup companies to make a pitch and participate in a live feedback session with a jury of leading investors, pharma dealmakers, and biotech business key opinion leaders who will evaluate the pitches and select the winner.
The assurance cookie is found and is being filtered in Google Analytics.
These cookies are used to collect information about how you interact
with our website and allow us to remember you. We use this
information in order to improve and customize your browsing
experience, and for analytics and metrics about our visitors both on
this website and other media. To find out more about the cookies we
use, see our